Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Breast Cancer in Pregnancy Register Study

Prospective and Retrospective Register Study of the German Breast Group (GBG) for Diagnosis and Treatment of Breast Cancer in Pregnancy

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Women who were diagnosed with breast cancer during their pregnancy may be registered in this trial. Data is collected on the foetal outcome 4 weeks after delivery, maternal outcome of pregnancy as well as the breast cancer therapy applied (treatment, response to chemotherapy, type of surgery), diagnostic procedures applied (palpation, US, mammogram) and the outcome of mother and child after 5 years of therapy.

Who May Be Eligible (Plain English)

Who May Qualify: - Cohort 1: Women with diagnosed by tissue sample (biopsy-confirmed) breast cancer during pregnancy - Cohort 2: Patients ≤ 40 years with histological confirmed breast cancer who are not pregnant (patients who have been pregnant recently can also be collected into this cohort) - willing to sign a consent form for data collection (for prospective participants) and biomaterial collection. For retrospective participants an willing to sign a consent form is not required as long as the data are anonymously captured Who Should NOT Join This Trial: - Cohort 1: Diagnosis of breast cancer outside the period of pregnancy - Cohort 2: Age at diagnosis of breast cancer \> 40 years Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Cohort 1: Women with histologically confirmed breast cancer during pregnancy * Cohort 2: Patients ≤ 40 years with histological confirmed breast cancer who are not pregnant (patients who have been pregnant recently can also be collected into this cohort) * Informed consent for data collection (for prospective participants) and biomaterial collection. For retrospective participants an informed consent is not required as long as the data are anonymously captured Exclusion Criteria: * Cohort 1: Diagnosis of breast cancer outside the period of pregnancy * Cohort 2: Age at diagnosis of breast cancer \> 40 years

Locations (1)

German Breast Group
Neu-Isenburg, Hesse, Germany